Fisker Inc. Announces Third Quarter 2023 Financial Results*
Fisker sees continued strong demand for its Ocean and delivered more cars in October than the entire third quarter. Fisker now delivering in ten countries, expected... Read more.
Westaim Announces Participation in Skyward Specialty Follow-On Offering
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO... Read more.
Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated... Read more.
The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board
NEW YORK–(BUSINESS WIRE)–The Central and Eastern Europe Fund, Inc. (NYSE: CEE), The European Equity Fund, Inc. (NYSE: EEA) and The New Germany Fund,... Read more.
AM Best Comments on Credit Ratings of James River Group Holdings, Ltd. and Its Subsidiaries
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has commented that the Credit Rating (ratings) of James River Group Holdings, Ltd. (JRG Holdings)... Read more.
Grid Dynamics to Ring Nasdaq Opening Bell on November 17, 2023
SAN RAMON, Calif.–(BUSINESS WIRE)–Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics” or the “Company”), a leader in enterprise-level... Read more.
Ryder Executive Vice President and CFO to Address Stephens Annual Investment Conference
MIAMI–(BUSINESS WIRE)–#RyderEverbetter—Ryder System, Inc. (NYSE: R) Executive Vice President and CFO John Diez to address the 2023 Stephens Annual... Read more.
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
Conference Call and Webcast November 14 at 8:00 AM Eastern Time / 7:00 AM Central Time Updated Amendment to Phase 2/3 ReMEDy2 AIS Protocol Aimed at Enhancing Patient... Read more.
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2024
FDA approves ATI-1501 for Metronidazole Oral Suspension 500mg/5mL and its brand name LIKMEZ™ Appili received an additional funding commitment from the U.S. Air... Read more.
Guerrilla RF Reports Third Quarter 2023 Results
Company demonstrates strong Year-over-Year revenue growth of 52%, driven by increase in automotive product sales GREENSBORO, N.C.–(BUSINESS WIRE)–$GUER–Guerrilla... Read more.